“The toxicology package included repeat-dose toxicity (up to 13 weeks in mice, 26 weeks in rats, and 52 weeks in monkeys, in vitro and in vivo genotoxicity,”
✓ VerifiedFDA pharmacology/toxicology review, p. 7Source ↗
Why that species
Monkey metabolic profile similar to human
“Monkey had a similar metabolic profile as the human profile.”
“In the chronic (26-week) oral rat study, mortality was seen at the HD of 48 mg/kg/day and CNS clinical signs (decreased activity, uncoordinated gait) at doses ≥ 24 mg/kg/day.”
✓ VerifiedFDA pharmacology/toxicology review, p. 7Source ↗
Species: general tox
Mouse (up to 13 weeks), rat (26 weeks) and cynomolgus monkey (52 weeks)
“The toxicology package included repeat-dose toxicity (up to 13 weeks in mice, 26 weeks in rats, and 52 weeks in monkeys,”
✓ VerifiedFDA pharmacology/toxicology review, p. 7Source ↗
Species: DART
Rat and rabbit
“A potential for adverse effects on development was identified in rat and rabbit studies.”
✓ VerifiedFDA pharmacology/toxicology review, p. 7Source ↗
Species: carcinogenicity
Tg rasH2 mouse (26-week) and rat (104-week)
“carcinogenicity (26-week in transgenic rasH2 mice, 104-week in rats)”
✓ VerifiedFDA pharmacology/toxicology review, p. 7Source ↗
Surrogate used in
No surrogate used; cenobamate tested directly in mice, rats and monkeys
“The toxicology package included repeat-dose toxicity (up to 13 weeks in mice, 26 weeks in rats, and 52 weeks in monkeys,”
✓ VerifiedFDA pharmacology/toxicology review, p. 7Source ↗